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The R2TP cochaperone complex plays a critical role
in the assembly of multisubunit machines, including
small nucleolar ribonucleoproteins (snoRNPs), RNA
polymerase II, and the mTORC1 and SMG1 kinase
complexes, but the molecular basis of substrate
recognition remains unclear. Here, we describe a
phosphopeptide binding domain (PIH-N) in the
PIH1D1 subunit of the R2TP complex that preferen-
tially binds to highly acidic phosphorylated proteins.
A cocrystal structure of a PIH-N domain/TEL2 phos-
phopeptide complex reveals a highly specific phos-
phopeptide recognition mechanism in which Lys57
and 64 in PIH1D1, along with a conserved DpSDD
phosphopeptide motif within TEL2, are essential
and sufficient for binding. Proteomic analysis of
PIH1D1 interactors identified R2TP complex sub-
strates that are recruited by the PIH-N domain in a
sequence-specific and phosphorylation-dependent
manner suggestive of a common mechanism of sub-
strate recognition. We propose that protein com-
plexes assembled by the R2TP complex are defined
by phosphorylation of a specific motif and recogni-
tion by the PIH1D1 subunit.INTRODUCTION
Molecular chaperones facilitate the folding and unfolding of
polypeptides and are essential for the assembly of large protein
complexes (Macario and Conway de Macario, 2005). The R2TP
complex was discovered as an HSP90 cochaperone in budding
yeast. The human complex consists of four subunits: RUVBL1,
RUVBL2, PIH1D1, and RPAP3 (Zhao et al., 2005). RUVBL1
(also known as Pontin, Ruv1, and Tip49a) and RUVBL2 (alsoknown as Reptin, Ruv2, and Tip49b) are essential and highly
conserved ATPases that belong to the adenosine triphospha-
tases associated with multiple activities (AAA+) family. Both
possess ATPase and protein and nucleic acid binding activity
and are involved in many biological processes, including chro-
matin remodeling, transcription regulation, ribonucleoprotein
complex biogenesis, nonsense-mediated mRNA decay, and
the DNA damage response. In the majority of these processes,
RUVBL1 and RUVBL2 function as components of larger com-
plexes, such as the R2TP (Jha and Dutta, 2009). RPAP3 contains
tetratricopeptide repeats involved in HSP90 binding (Back et al.,
2013; Jime´nez et al., 2012) and potentially other protein-protein
interactions. The last member of the R2TP complex (PIH1D1)
contains a predicted structural domain with unknown function.
Evidence supports a role for the R2TP complex along with
HSP90 in the assembly of a number of multisubunit mole-
cular machines, including small nucleolar ribonucleoproteins
(snoRNPs), spliceosomal snRNP U4, RNA polymerase II, and
mTORC1 and SMG1 complexes (Ahn et al., 2013; Boulon
et al., 2008, 2010; Horejsı´ et al., 2010; Kim et al., 2013; Zhao
et al., 2008). Nonetheless, a molecular explanation of how the
R2TP complex recognizes such diverse substrates remains
elusive (Machado-Pinilla et al., 2012). We previously reported
that PIH1D1 binds to a casein kinase 2 (CK2)-phosphorylated
form of the cochaperone TEL2. TEL2, along with TTI1 and
TTI2, forms the TTT complex, which is critical for the assembly
of the phosphatidylinositol 3-kinase-related kinases (Hurov
et al., 2010; Takai et al., 2010). Our previous study revealed
that CK2 phosphorylation of TEL2 is essential for direct binding
to PIH1D1, and its disruption leads to the destabilization of
mTOR, SMG1, and, to a lesser extent, ATM, ATR, and DNA-
PKcs (Horejsı´ et al., 2010). Given that PIH1D1 is not predicted
to contain any of the known phosphopeptide binding domains,
such as 14-3-3, FHA, BRCT,WD40,WW, and Polo box domains,
it is unclear how it recognizes phosphorylated TEL2 (pTEL2).
Furthermore, whether phosphorylation-dependent binding rep-
resents a universal substrate recognition mechanism for the
R2TP complex has not been previously explored.Cell Reports 7, 19–26, April 10, 2014 ª2014 The Authors 19
Here, we demonstrate that the N-terminal PIH1D1 region PIH-
N is a phosphopeptide binding domain structurally unrelated
to previously reported phosphopeptide binding proteins that
is required for recognition of phosphorylated substrates,
whereas the C-terminal region of PIH1D1 binds to the other com-
ponents of the R2TP complex. The crystal structure of PIH-N
domain fragment bound to the phosphorylated TEL2 peptide
suggests that the major interacting site for the PIH-N domain is
a short conserved DpS491DD motif, previously described as a
CK2 phosphorylation site (Ahn et al., 2013; Horejsı´ et al., 2010).
The PIH-N domain contains two conserved residues (Lys57
and Lys64) that directly interact with the TEL2 pSer491 and
are essential for binding in vitro and in vivo. Proteomic and
in silico screens identified several PIH1D1 phosphorylation-
dependent binding partners. Among these, we have confirmed
a direct phosphorylation-dependent interaction with human
ecdysoneless (ECD), previously implicated in the stabilization
of the tumor suppressor p53, mediated by a motif identical to
the TEL2 DpSDD sequence.
RESULTS
PIH1D1 Functional Domains
First, to gain insight into the apparent phosphopeptide binding
activity of human PIH1D1 and its interactions with R2TP complex
components, we performed domain-mapping experiments.
Immunoprecipitation studies mapped the binding of phospho-
rylated TEL2 to a region within the N-terminal 250 amino acids
of PIH1D1, whereas RUVBL1, RUVBL2, and RPAP3 interacted
via a separate region in its C terminus (Figure 1A). Additional
sequence homology and limited proteolysis analysis (Fig-
ure S1A), coupled with isothermal titration calorimetry (ITC) mea-
surements on a series of truncation mutants, was initially used to
define a smaller, stable fragment (1–180) that was sufficient to
bind to a TEL2 peptide phosphorylated on Ser491 with an affinity
of 3.5 mM, comparable to the affinity of other phosphopeptide
binding domains for their substrates (Figures 1B and S1C;
Table S1) (Lloyd et al., 2009). A diphosphorylated peptide
incorporating Ser487 located just upstream of Ser491 bound
with 2- to 3-fold higher affinity, whereas binding to a peptide
phosphorylated only at Ser487 was substantially weaker. Addi-
tional removal of the poorly conserved N-terminal region did
not detectably compromise interactions (Table S1). Although it
has previously been shown that Ser487 and Ser491 are both
phosphorylated by CK2 in vivo, Ser487 is not conserved in
TEL2 orthologs (Figure 1C), suggesting that CK2 phosphory-
lation of Ser491 constitutes the switch for TEL2 recognition
by PIH1D1 and its orthologs in all eukaryotes. Furthermore,
sequence comparison reveals that Ser491 in human TEL2 is
embedded in an absolutely conserved DpSDD motif (Figure 1C),
and, accordingly, ‘‘pep-spot’’ analysis showed that PIH1D1 in-
teracts only with TEL2 phosphopeptides in which the DpSDD
motif is intact (Figure 1D). In order to further probe interactions
with the conserved acidic CK2 substrate motif within TEL2,
and based on our structural studies described below, all subse-
quent ITC titrations used shorter (8-mer) peptides (Table S1). In
these experiments, phosphopeptides in which each of the three
aspartate residues were individually substituted by alanine all20 Cell Reports 7, 19–26, April 10, 2014 ª2014 The Authorsfailed to show any significant quantifiable binding, and replace-
ment of pSer491 with Glu as a phosphopeptide mimic also
severely compromised interactions (Figure 1E). Indeed, substitu-
tion of pSer491 with pThr significantly reduced binding, even in
the context of longer TEL2 peptides, revealing amarked discrim-
ination in favor of phosphoserine-containing motifs (Figure 1F).
Altogether, these data show that the PIH1 homology region
encompasses two structurally and functionally separable do-
mains—hereafter referred to as PIH-N and PIH-C—which are
linked by an intervening region of variable length and sequence
(Figure S1). Furthermore, they suggest that the major interacting
site for the PIH-N domain of PIH1D1 (and budding yeast Pih1) is
a short DpSDD motif that encompasses the only amino acids
conserved between TEL2 orthologs from humans to yeast.
Crystal Structure of PIH1-N Domain Alone and Bound
to TEL2 pSer491 Peptide
To investigate the molecular basis of the phosphopeptide-spe-
cific binding activity of the PIH-N domain, we solved the crystal
structures of PIH1D1 domain fragments alone and bound to the
TEL2 pSer491 peptide (Table S2). The structure of the peptide-
free PIH1D1 51–180 fragment shows that the PIH-N domain
adopts an unusual bbabbbaa topology (Figure 2A) that is unique
among previously reported phosphopeptide-interacting pro-
teins and modules. The structure of the PIH-N domain in the
PIH1D1-pTEL2 phosphopeptide complex (Figure 2B) is essen-
tially identical except for the fact that helix a1 located between
b2 and b3 is disordered. In the structure of the PIH1D1-pTEL2
complex, 11 residues of the peptide are defined in the electron
density maps and bind to a shallow, positively charged groove
formed by the b sheet and an extended C-terminal segment (Fig-
ures 2B and S2). Five N-terminal residues, including pSer487,
are disordered, suggesting that the small binding contribution
of the additional phosphosite results from weak, nonspecific
electrostatic interactions that are not associated with a single
defined conformation. The most significant interactions of
PIH1D1 are formed with the core DpSDD motif in TEL2, to the
extent that the only intermolecular hydrogen bonds seen in
the complex involve these four residues (Figure 2C). Indeed,
the structure nicely explains the high degree of conservation
of the DpSDD motif. Although it appears that substitution of
aspartate in the pSer 1 position with glutamate could be
accommodated, the pattern of hydrogen bonding of the aspar-
tates in the +1 and +2 positions along with their steric envi-
ronment indicates that even conservative substitution with
glutamate would be detrimental to binding (Figure 2D).
From the perspective of the PIH-N domain itself, only three
(Lys57, Lys64, and Arg168) of the five basic residues that con-
tribute to the positively charged binding surface make hydrogen
bonding interactions with TEL2. Of these, only Lys57 and Lys64
interact directly with the TEL2 pSer491 phosphoryl group and
constitute the only basic residues conserved across PIH1D1
orthologs from yeast to humans (Figure S1B). Arg168 forms
the base of the phosphopeptide binding site, making hydro-
gen bonds with main-chain atoms of the bound ligand in a
manner reminiscent of the binding mode observed in BRCA1
C terminus phosphopeptide complexes (BRCA1 Arg1699 and
MDC1 Arg1933) (Clapperton et al., 2004; Stucki et al., 2005).
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Figure 1. PIH-N Domain Is Responsible for Binding of PIH1D1 to Phosphorylated TEL2 but Not Components of R2TP Complex
(A) Top, schematic representation of theWT and truncated PIH1D1 proteins. The region of highest homologywith budding yeast PIH1 is highlighted in light green.
Bottom, interaction of PIH1D1 with components of R2TP complex and TEL2. RUVBL1, RUVBL2, RPAP3, and TEL2 were immunoprecipitated from human
embryonic kidney 293T (HEK293T) cells transiently transfected with FLAG-tagged PIH1D1 proteins or empty vector expressing FLAG.
(B) Isothermal titration calorimetry (ITC) analysis of PIH1D1 1–180 binding to singly and doubly phosphorylated TEL2 peptides.
(C) A core DSDD motif is absolutely conserved in TEL2 orthologs from yeast humans (Hs, Homo sapiens; Mm,Mus musculus; Gg, Gallus gallus; Dr, Danio rerio;
Ce, Caenorhabditis elegans; Sc, Saccharomyces cerevisiae).
(D) 1D pep-spot array containing TEL2 phosphopeptides in which polyalanine tracts were substituted for regions flanking the core DpS491DD motif.
(E) ITC analysis of PIH1D1 51–180 binding toWT andmutant 8-mer peptides encompassing the core conservedDpSDDTEL2motif. NI, no quantifiable interaction.
(F) ITC analysis of WT TEL2 peptide and a variant in which pSer491 was substituted with pThr.
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Figure 2. PIH-N Domain Structure and Tel2 Interactions
(A) Left, ribbons representation of the uncomplexed PIH1D1 PIH-N domain. Right, schematic representation of the overall a + b topology. b0 (cyan) contains four
residues of vector encoded sequence that most likely mimics the conformation of native sequence that was removed in construction of the crystallizable
fragment.
(B) Structure of the PIH-N domain of PIH1D1 bound to a TEL2 phosphopeptide. The protein is shown as ribbons and the phosphopeptide as a stick repre-
sentation. The loop containing a1 is disordered in the phosphopeptide complex structure and is shown schematically.
(C) The core DpSDDmotif in TEL2 is secured via a network of salt bridge and hydrogen bonding interactions with three basic residues: Lys57, Lys64, and Arg168.
(D) Aspartates in the pSer +1 and +2 positions (and, to a lesser extent the 1 position) within the TEL2 peptide pack tightly against the protein surface.
(E) ITC isotherms show that mutation of the core-motif-interacting side chains from Lys57, Lys64, and Arg168 are most deleterious to TEL2 binding. The asterisk
shows that the titration with K64A was carried out at higher concentration/molar ratio, but, nonetheless, no interaction was detectable.
(F) Lys57 and Lys64, but not R2TP, are essential for TEL2 binding components in vivo. RUVBL1, RUVBL2, RPAP3, and TEL2 were immunoprecipitated from
HEK293T cells transiently transfected with FLAG-tagged WT PIH1D1 or PIH1D1 with K64A and K57A mutations.
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A B Figure 3. Identification of Phosphopeptide-
Specific Interacting Partners of PIH1D1
(A) FLAG-tagged WT PIH1D1 and K64A mutant
immunoprecipitates with RPAP3, RUVBL1, and
RUVBL2 subunits of the R2TP complex from
HEK293T cells. FLAG-tagged WT PIH1D1, but
not the K64A phosphopeptide binding mutant,
immunoprecipitates UBR5, RPB1, SNRP116, and
TEL2. Proteins were immunoprecipitated from
HEK293T cells transiently transfected with FLAG-
tagged PIH1D1 proteins or empty vector express-
ing FLAG.
(B) FLAG-tagged TEL2, SNRP116, and UBR5 un-
treated with lambda phosphatase bind to recom-
binant GST-tagged WT PIH1D1 but not K64A
mutant. Interactions with GST-tagged WT PIH1D1
are disrupted by lambda phosphatase treatment.
FLAG-tagged RPAP3 untreated or treated with
lambda phosphatase binds to GST-tagged WT
PIH1D1 and K64A mutant.Accordingly, mutation of each of these residues to alanine
(K57A, K64A, and R168A) essentially abolished TEL2 phospho-
peptide binding as judged by ITC, and smaller but nonetheless
significant effects were observed for mutations of basic residues
at more peripheral positions (Figure 2E; Table S1). In addition,
both K57A and K64A mutants of full-length PIH1D1 failed to
immunoprecipitate endogenous TEL2 from whole-cell extract
but nonetheless retained binding to the other components
of the R2TP complex mediated through the PIH-C region
(Figure 2F).
Interestingly, both phosphopeptide-interacting lysines are
absent in PIH1D2 but are substituted with arginine in another
PIH1D1 ortholog, Kintoun, a regulator of dynein assembly
(Omran et al., 2008). Although we have been unable to test
PIH1D2-pTEL2 interactions by ITC, the lack of conservation
at these crucial positions renders a phosphopeptide binding
activity unlikely. However, the PIH-N domain of Kintoun does
show some weak, but nonetheless significant, binding to the
pTEL2 peptide (Figure S3), suggestive of a phosphopeptide
binding capacity that is, presumably, associated with an altered
overall target sequence specificity.
Proteomic Analysis of PIH1D1 Phosphopeptide-Specific
Interactions
Our data raised the intriguing possibility that R2TP complex
substrates may be defined by their ability to bind to PIH1D1 in
a phosphopeptide-specific manner. To investigate this further
and identify previously unreported R2TP complex substrates,
we conducted a comparative proteomic analysis of wild-type
(WT) PIH1D1 and the K64A mutant, which is compromised
for phosphopeptide binding (Table S3). Among others, TEL2,Cell Reports 7, 19SNRP116, UBR5, and RNA polymerase
II subunit RPB1 were identified by
mass spectrometry specifically with WT
PIH1D1, but not the K64A mutant, and
were confirmed by immunoprecipitation
and western blotting (Figure 3A). Immu-noaffinity purified SNRP116 and UBR5 also bound to WT
PIH1D1 fused to glutathionine S-transferase (GST) but not
GST-K64A PIH1D1. Furthermore, lambda phosphatase treat-
ment of the immunoprecipitated SNRP116 and UBR5 disrupted
their binding to GST-WT PIH1D1, indicating that the interactions
are phosphorylation dependent, whereas RPAP3 bound to
the GST-tagged PIH1D1 regardless of phosphorylation status
or the integrity of Lys64 (Figure 3B). These results reveal that,
analogous to TEL2 binding, SNRP116 and UBR5 interact with
the PIH domain of PIH1D1 in a phosphorylation-dependent
manner.
Minimal PIH-N Consensus Sequence and In Silico
Identification of Potential Substrates
Next, we determined a minimal consensus sequence necessary
for TEL2 phosphopeptide interaction with the PIH-N domain
(Figure 4A). To this end, we assayed binding to a TEL2 pep-
spot substitution array in which each residue in the polypeptide
was substituted by all other amino acids. From this analysis, we
derived a phosphopeptide binding consensus motif (D[S/T]DD
[D/E]) that was then used in an in silico screen to identify
additional potential substrates of the R2TP complex. Proteins
containing the PIH-N domain binding consensus sequence
included ECD, UBR5, PTGES3, EIF5B, TRP12, and SFRS18
(Figure 4B). Of these, we chose to further characterize and
validate the interaction with ECD, which is involved in p53
stabilization and regulation of retinoblastoma phosphorylation
(Kim et al., 2009; Zhang et al., 2006) and contains two PIH-N
domain binding sequences surrounding CK2 consensus phos-
phorylation sites Ser505 and Ser518. In contrast to the unphos-
phorylated ECD peptide, an ECD peptide phosphorylated at–26, April 10, 2014 ª2014 The Authors 23
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Figure 4. A Minimal Consensus Sequence for
PIH1 Domain Binding Reveals Potential R2TP
Substrates
(A) A pep-spot array was synthesized in which each
residue in the TEL2 phosphopolypeptide (16 amino
acids) was substituted with all other amino acids.
Peptides were spotted on a peptide array and incu-
bated with purified 63 His-tagged PIH1D1 fragment
1–180.
(B) Peptide pull-down of PIH1D1 from HEK293T
whole-cell extract. PIH1D1 and RPAP3 were pulled
down from whole-cell extract by biotinylated pep-
tides containing the phosphorylated consensus PIH-
N domain binding sequence. Negative control (line 8)
was unphosphorylated TEL2 peptide.
(C) ECD peptide binds PIH1D1 in a phosphopeptide-
specific manner. PIH1D1 was pulled down from
HEK293T whole-cell extract by biotinylated ECD
peptide containing phosphorylated Ser505 but not
with nonphosphorylated ECD peptide.
(D) ITC analysis of ECD binding (RPNESDpS505-
DDLDDY) to PIH1D1 1–180.
(E) FLAG-tagged WT PIH1D1, but not K64A mutant,
immunoprecipitates ECD from HEK293T whole-cell
extract. Proteins were immunoprecipitated from
HEK293T cells transiently transfected with FLAG-
tagged PIH1D1 proteins or empty vector expression
FLAG.
(F) Mutation of ECD Ser505 and Ser518 to Ala disrupt
binding of FLAG-tagged ECD to GST-tagged WT
PIH1D1.
(G) Mutation of PIH1D1 leads to decreased levels of
p53 after DNA damage. Retinal pigment epithelium
cells were stably transfected with FLAG-tagged WT
PIH1D1, PIH1D1 K64A, or empty vector expressing
FLAG. The cells were treated with control siRNA
(si con) or siRNA targeting 50 untranslated region of
PIH1D1 cDNA and irradiated with 5Gy. Samples were
collected 1 hr after irradiation.Ser505 efficiently pulled down PIH1D1 from whole-cell extract
(Figure 4C) and exhibited a binding affinity of 16 mM in ITC anal-
ysis (Figure 4D). Endogenous ECD also immunoprecipitated WT
PIH1D1 but failed to interact with PIH1D1 K64A (Figure 4E).
Conversely, mutation of the predicted CK2 sites in ECD
(Ser505 and Ser518) abolished interaction with PIH1D1 (Fig-
ure 4F). Thus, like TEL2, ECD is recruited to the R2TP complex
through interactions of the PIH-N domain of PIH1D1 with the
conserved DSDD motif, possibly in a CK2 phosphorylation-
dependent manner. Given that ECD, UBR5, and TEL2 are impor-
tant for the regulation of p53 (Ling and Lin, 2011; Reid et al.,
2013; Smits, 2012; Takai et al., 2007), we sought to determine
if PIH1D1 also impacts on p53 function. To this end, we depleted
PIH1D1 and analyzed p53 stability and phosphorylation on
Ser15 after DNA damage. Depletion of PIH1D1 with two dif-
ferent small interfering RNAs (siRNAs) resulted in reduced p5324 Cell Reports 7, 19–26, April 10, 2014 ª2014 The Authorslevels and a loss of Ser15 phosphorylation
after DNA damage (Figures S4A and S4B).
To determine whether this effect is depen-
dent on PIH-N phosphopeptide binding
activity, we stably transfected retinal pig-ment epithelium cells with WT PIH1D1, PIH1D1 K64A mutant,
or empty vector and selected single clones expressing PIH1D1
at levels similar to endogenous (Figure S4C). Depletion of
PIH1D1 with siRNA targeting the 50 untranslated region of
PIH1D1 from cells reconstituted with WT PIH1D1 rescued levels
of p53 protein and phosphorylation after DNA damage to normal
levels, which was in contrast to PIH1D1 K64A. Therefore, we
conclude that the phosphopeptide binding ability of PIH1D1 is
crucial for the function of R2TP complex (Figure 4G).
DISCUSSION
Along with HSP90, the R2TP complex has been implicated in
the assembly of large protein or ribonucleoprotein complexes
in the cytoplasm and the nucleus. In contrast to the two
AAA+ ATPases that are present in many different multisubunit
complexes (RUVBL1 and RUVBL2), PIH1D1 and RPAP3 are
specific to the R2TP complex and are likely to define substrate
binding, potentially via interaction with the tetratricopeptide
repeats of RPAP3. Nevertheless, RUVBL1 and RUVBL2 are
known to be important for assembly of R2TP complex substrates
into an appropriate functional conformation (Machado-Pinilla
et al., 2012). However, a mechanistic explanation that defines
how the R2TP complex is able to recognize and facilitate assem-
bly of diverse substrates is largely unknown.
The results presented here reveal a previously unrecognized
phosphopeptide binding domain (PIH-N) within the PIH1D1 sub-
unit of the R2TP complex that preferentially binds to acidic phos-
phorylated proteins with high specificity. Structural analysis of
the PIH-N domain bound to the TEL2 phosphopeptide estab-
lished a unique mechanism of phosphopeptide recognition and
identified Lys57 and Lys64 in PIH1D1 as essential for phospho-
peptide binding. Both lysines, as well as theCK2 phosphorylated
TEL2 binding motif DpSDD, are highly conserved in PIH1D1 and
TEL2 orthologs from yeasts to human, indicating a common
mechanism for substrate recognition by PIH-N domain. Through
proteomic and in silico analysis, we demonstrate that the PIH-N
domain binds to SNRP116, UBR5, RPB1, and ECD in a phos-
phorylation-dependent manner analogous to TEL2. Thus, we
suggest that substrates are marked for assembly by the R2TP
complex through phosphorylation of a short, highly acidic motif
by CK2 (or other acidophilic kinases), which is then recognized
by the phosphopeptide binding function of the PIH1D1 subunit.
The emergence of HSP90 inhibitors as successful cancer ther-
apeutics has highlighted the importance of protein complex as-
sembly and chaperone activities in cancer cells. Given that the
R2TP complex works in conjunction with HSP90 to assemble
multisubunit protein and ribonucleoprotein complexes, R2TP
complex inhibitors could also be of value in a clinical setting.
Small molecules that block the PIH-N phosphopeptide binding
domain by mimicking the DpSDD motif would be predicted to
prevent the RT2P complex from recognizing its substrates.
Notably, the PIH1D1 subunit is overexpressed in several breast
cancer cell lines (Kamano et al., 2013), which may reflect a
dependency of the tumor growth for R2TP complex activity.
Therefore, it is possible that inhibitors of PIH-N domain interac-
tions could be used as an anticancer therapeutic for tumors
that are overreliant on such chaperone activities.
EXPERIMENTAL PROCEDURES
X-Ray Crystallography
Recombinant selenomethionine-substitutedhumanPIH1D1 (51–180)wascrys-
tallized in complexwithadiphosphopeptide (NH2-YAGSDpSDLDpSDDEFVPY-
CONH) encompassing residues 483–497 of human TEL2 by sitting drop vapor
diffusion with an IMPAX nano-dispensing robot. Crystals grew from a 8 mg/ml
solutionof complex in 20mMTris (pH8.0), 150mMNaCl, and0.5mM tris(2-car-
boxyethyl)phosphine (TCEP) equilibrated well solution containing 32% w/v
polyethylene glycol (PEG) 4000, 100 mM sodium acetate, and 100 mM Tris
(pH 8.5) as precipitant, transferred to a cryo-protectant containing protein
buffer and mother liquor supplemented with 20% v/v glycerol, and flash frozen
in liquid nitrogen.All datawere collectedat DiamondLight Source. Imageswere
indexed, integrated, and scaled with MOSFLM/SCALA (CCP4). Phases for the
PIH1D1-pTEL2 complex were determined by single-wavelength anomalous
diffraction and were of sufficient quality to enable a partial model of the two
PIH1D1-pTEL2 complexes in the crystallographic asymmetric unit to be builtautomatically with Buccaneer (CCP4). All manual model building was carried
out withCoot (Emsley andCowtan, 2004), and structure refinementwas carried
out with Phenix (Terwilliger, 2002). The structure of unbound PIH1D1 (51–180)
was crystallized by microseeding and vapor diffusion from 2% PEG 400 (v/v),
20% methoxy PEG 5000, and 0.1 M imidazole (pH 7.0). The structure was
determined by molecular replacement using the final refined protein co-
ordinates derived from the structure of the complex as a search model with
PHASER (McCoy, 2007) and refined against data extending to a 1.58 A˚ resolu-
tion. Crystallographic statistics are reported in Table S2.
Isothermal Titration Calorimetry
ITC was carried out with an ITC-200 calorimeter (MicroCal). Proteins were pre-
pared by dialysis against 20 mM Tris (pH 8.0), 150 mM NaCl, and 0.5 mM
TCEP. Synthetic phosphopeptides (Cambridge Peptides) were desalted with
NAP5 columns (GE Healthcare) equilibrated in 20 mM Tris (pH 8.0), 150 mM
NaCl, and 0.5 mM TCEP and diluted to the appropriate concentration with
dialysis buffer. Protein concentrations were determined by UV spectrometry.
A typical experiment involved 19 3 2 ml injections of 800 mM peptide from
the injection syringe into 80 mM protein in the sample cell. All measurements
were carried out at 20C. Data were analyzed with the Origin-based software
provided by the manufacturers.
Mass Spectrometry Analysis and Protein Identification
SYPRO ruby-stained polyacrylamide gel slices (1–2 mM) were excised with a
scalpel and processed for mass spectrometry with the JANUS automated
liquid handling system (PerkinElmer).
In Silico Screen for Proteins Containing PIH1 Binding Consensus
Sequence
Proteins containing the consensus bindingmotif D[S/T]DD[E/D] were identified
with the PROSITE database (http://prosite.expasy.org) tools. The resulting list
of candidates was filtered with the criteria that the site is at least conserved in
mammals and that it has previously been reported as phosphorylated in vivo.
For peptide pull-down assay, we chose proteins that were functionally most
likely to bind to the R2TP complex.
A detailed summary of all procedures used in this study can be found in the
Supplemental Experimental Procedures.
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The Protein Data Bank accession numbers for the crystal structures of the
unbound PIH1D1 PIH-N domain and its complex with the pTel2 peptide re-
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